<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0220401.ref021">
 <label>21</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Lackenby</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Besselaar</surname>
   <given-names>TG</given-names>
  </name>, 
  <name>
   <surname>Daniels</surname>
   <given-names>RS</given-names>
  </name>, 
  <name>
   <surname>Fry</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Gregory</surname>
   <given-names>V</given-names>
  </name>, 
  <name>
   <surname>Gubareva</surname>
   <given-names>LV</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017</article-title>. 
  <source>Antivir Res</source>. 
  <year>2018</year>;
  <volume>157</volume>:
  <fpage>38</fpage>–
  <lpage>46</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.07.001</pub-id>
  <?supplied-pmid 29981793?>
  <pub-id pub-id-type="pmid">29981793</pub-id>
 </mixed-citation>
</ref>
